M. Uchihara

发表

Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C

M. Kurosaki, N. Izumi, H. Nakanishi, 2005, Intervirology.

Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C.

N. Enomoto, M. Kurosaki, N. Izumi, 2005, Journal of hepatology.

A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high‐dose daily interferon alfa plus ribavirin and intravenous twice‐daily treatment with interferon beta

N. Izumi, Y. Asahina, J. Itakura, 2001, Hepatology.

Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of Interferon

N. Izumi, F. Marumo, T. Akiba, 1998, Nephron.

Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long‐term survival

M. Kurosaki, N. Izumi, T. Kitamura, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load

M. Kurosaki, N. Izumi, Y. Asahina, 2004, Intervirology.

Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens.

N. Izumi, Y. Asahina, J. Itakura, 2003, Journal of hepatology.

Hepatic Iron Accumulation and Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

N. Izumi, Y. Asahina, J. Itakura, 2003 .

Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients.

M. Kurosaki, N. Izumi, T. Kitamura, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

V1-receptor mediated GSH efflux by vasopressin from rat hepatocytes.

N. Izumi, Y. Asahina, F. Marumo, 1992, Life sciences.

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha‐2b and ribavirin

M. Kurosaki, N. Izumi, T. Kitamura, 2007, Journal of viral hepatitis.

Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C

N. Enomoto, N. Izumi, F. Marumo, 1996, Digestive Diseases and Sciences.

Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

N. Enomoto, N. Izumi, F. Marumo, 1996, Digestive diseases and sciences.

Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis

N. Izumi, C. Sato, M. Uchihara, 1992, Hepatology.

Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis.

M. Kurosaki, N. Izumi, Y. Asahina, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation

N Enomoto, N. Enomoto, N. Izumi, 2001, Cancer.

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

N. Enomoto, M. Kurosaki, N. Izumi, 2005, Intervirology.

Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C.

N. Izumi, Y. Asahina, J. Itakura, 2003, Journal of hepatology.

A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression.

N. Enomoto, N. Izumi, Y. Asahina, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study.

N. Izumi, M. Uchihara, N. Horikawa, 2003, General hospital psychiatry.

Hemolysis, elevated liver enzymes, and low platelets syndrome associated with primary anti-phospholipid antibody syndrome.

N. Enomoto, N. Izumi, F. Marumo, 1997, Internal medicine.

Laparoscopic ablation therapy for hepatocellular carcinoma. Clinical significance of a newly developed laparoscopic sector ultrasonic probe

N. Izumi, Y. Asahina, J. Itakura, 2003 .

Radiofrequency Tumor Ablation for Hepatocellular Carcinoma

N. Izumi, Y. Asahina, J. Itakura, 2002 .

[Ulcerative colitis developed after acute exacerbation of chronic hepatitis B].

N. Izumi, Y. Asahina, J. Itakura, 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography.

N. Izumi, M. Koike, Y. Asahina, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Inhibition of acetaminophen activation by ethanol and acetaldehyde in liver microsomes.

F. Marumo, C. Sato, T. Nouchi, 1991, Life sciences.

Cytochrome P450 2C19 (CYP2C19) genotype status is not associated with cure rates of dual therapy with rabeprazole and amoxicillin for Helicobacter pylori

N. Izumi, Y. Asahina, J. Itakura, 2001 .

[A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate].

N. Enomoto, N. Izumi, F. Marumo, 1996, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[High-sensitivity C-reactive protein (hs-CRP): a promising biomarker for the screening of non-alcoholic steatohepatitis (NASH)].

N. Izumi, M. Uchihara, 2006, Nihon rinsho. Japanese journal of clinical medicine.

[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1].

N. Izumi, Y. Asahina, J. Itakura, 2004, Gan to kagaku ryoho. Cancer & chemotherapy.